Evaluation of an Mhealth Intervention to Increase Adherence to Triage of HPV+ Women
NCT02561208 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2020-01-27
Summary
Cervical cancer remains a serious health problem, particularly in developing countries. It is the leading cause of cancer death among women and mainly affects women of low socioeconomic status.
Evidence has shown that HPV-test self-collection can reduce social and health services barriers to screening and increase coverage. However, high coverage will not result in a decrease of disease burden if women are not diagnosed/treated. The HPV-test indicates whether a woman is positive or not, and a triage test is needed to identify HPV-positive women who need to perform diagnostic procedures. Several triage methods are available. In Argentina, cytology is used as triage method; therefore, all HPV-positive women who have performed self-collection at home need to attend health centers to undergo cytology. However, the proportion of women who have completed triage is low, therefore new innovative strategies are needed to increase attendance to cytology of these women.
This study will be carried out in Jujuy, one of the Argentinian provinces with highest cervical cancer mortality rates and where HPV- self-collection has been introduced as programmatic strategy for screening under-users.
This trial is population-based cluster-randomized study that aims to evaluate the effectiveness of a mHealth intervention versus usual care to increase adherence to cytological triage among women with HPV-positive self-collected tests.
An overall number of 240 Community Health Workers (CHWs) from the Primary Health Care System (PHCS) of the Province of Jujuy will be randomized into two groups:
1. mHealth Intervention Group: Women with HPV self-collected tests will receive a mixed intervention which includes counseling through an interactive Apps specifically devised to increase adherence to triage which will be run on a tablet, and SMS text messages to remind them to attend triage. In addition, Heads of CHWs, chiefs of gynecology services and CHWs will receive reminders via e-mails and SMS message to contact women if after 60 days from the HPV-results HPV+ they have not performed triage.
2. Usual Care Group: Women with HPV self-collected tests receive usual care.
A database built specifically for the study will be used; it will include data about randomization Group, agreement to participate in the study and socio-demographic data. Data on HPV-testing and triage will be uploaded importing the data from SITAM, using the Unique Identification Number (DNI).
Data Analysis
Effectiveness to enhance adherence to cytological triage: Adherence to triage will be considered for each CHW. This will be defined as the number of women with triage smears within 30, 60 and 90 days. There will be a comparison of the percentage of HPV-positive women that did the Pap test within those time intervals in the mHealth intervention group and the Usual Care group. The effect of the mHealth intervention against usual care will be estimated using a means difference test or a non-parametric test for independent samples.
Conditions
- Patient Adherence
Interventions
- OTHER
-
mHealth Intervention Group
Women with HPV self-collected tests will receive a mixed intervention which includes counseling through an interactive Apps specifically devised to increase adherence to triage which will be run on a tablet, and SMS text messages (SMS message) to remind them to attend triage. In addition, Heads of CHWs, chiefs of gynecology services and CHWs will receive reminders via e-mails to contact women if after 60 days from the HPV-results HPV+ they have not performed triage.
Sponsors & Collaborators
-
Centro de Estudio de Estado y Sociedad
lead OTHER
Principal Investigators
-
Silvina Arrossi, PhD · Center of Study of State and Society
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
More Related Trials
-
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
NCT06843720 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Human Papilloma Virus (HPV) Self-testing to Increase Screening Uptake
NCT02095561 ·Status: COMPLETED ·Phase: NA
-
Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening
NCT07186530 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
My Self-Sampling for HPV Awareness, Results, and Empowerment
NCT07296159 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
NCT04679675 ·Status: COMPLETED ·Phase: NA
-
HPV Self-Test Intervention in Ohio Appalachia
NCT02460237 ·Status: COMPLETED ·Phase: NA
-
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
NCT04411849 ·Status: COMPLETED ·Phase: NA
-
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315 ·Status: COMPLETED
-
Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
NCT03613493 ·Status: TERMINATED ·Phase: NA
-
HPV Self-sampling for Underscreened Latinas
NCT06439706 ·Status: COMPLETED ·Phase: NA
-
Human Papilloma Virus (HPV) Vaccination Among Rural African American Primary Caregivers and Daughters
NCT00937287 ·Status: COMPLETED
-
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01588301 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
HPV DNA Testing Through Mobile Mammography Unit
NCT03551028 ·Status: COMPLETED ·Phase: NA
-
Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women
NCT02255084 ·Status: COMPLETED ·Phase: NA
-
Comparing Strategies for Implementing Primary HPV Screening
NCT04371887 ·Status: UNKNOWN ·Phase: NA
-
Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon
NCT07181278 ·Status: RECRUITING ·Phase: NA
-
Human Papilloma Virus (HPV) Self-collection and Women Adherence
NCT05059015 ·Status: UNKNOWN ·Phase: NA
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
NCT04611022 ·Status: RECRUITING ·Phase: NA
-
Combined Incentive Actions, Focusing on Primary Care, to Improve Cervical Cancer Screening in Women Residing in Socio-economically Disadvantaged and Untracked Geographical Areas: a Hybrid Efficacy and Implementation Trial
NCT04312178 ·Status: COMPLETED ·Phase: NA
-
A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families
NCT04380623 ·Status: UNKNOWN ·Phase: NA
-
Human Papilloma Virus (HPV) Knowledge and Attitudes and the Role of (SES) Socioeconomic Status and Ethnicity
NCT01105000 ·Status: COMPLETED
-
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01014026 ·Status: COMPLETED ·Phase: PHASE3
-
Self-Collection and Human Papillomavirus (HPV) Testing in Unscreened Women: a Feasibility Study in Brazil
NCT03713697 ·Status: COMPLETED ·Phase: NA
-
Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention
NCT05524480 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Community-Driven Cervical Cancer Prevention in Western Kenya
NCT02124252 ·Status: COMPLETED ·Phase: NA